namita-thapar

Emcure Pharmaceuticals

Shark Tank Investor Namita Thapar's Mega 293x Return on Emcure Pharma IPO!

Exciting news as Namita Thapar gears up to make a whopping 293-fold return on her Emcure Pharmaceuticals investment in the upcoming IPO. Read more!

See more

Emcure Pharmaceuticals IPO GMP

Emcure Pharmaceuticals IPO Buzz: All You Need to Know

Exciting updates on the Emcure Pharmaceuticals IPO and whether you should dive in!

See more

Emcure Pharma IPO GMP

Emcure Pharma IPO: Subscription Frenzy and Record GMP Prices

Emcure Pharma IPO sees huge demand with shares selling at a premium of ₹333 in the grey market. Check out the subscription status and latest updates!

See more